SG32993G - Therapeutic particles - Google Patents

Therapeutic particles

Info

Publication number
SG32993G
SG32993G SG329/93A SG32993A SG32993G SG 32993 G SG32993 G SG 32993G SG 329/93 A SG329/93 A SG 329/93A SG 32993 A SG32993 A SG 32993A SG 32993 G SG32993 G SG 32993G
Authority
SG
Singapore
Prior art keywords
therapeutic particles
therapeutic
particles
Prior art date
Application number
SG329/93A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SG32993G publication Critical patent/SG32993G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG329/93A 1985-03-21 1993-03-23 Therapeutic particles SG32993G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/714,606 US4755387A (en) 1985-03-21 1985-03-21 Therapeutic particles

Publications (1)

Publication Number Publication Date
SG32993G true SG32993G (en) 1993-05-21

Family

ID=24870739

Family Applications (1)

Application Number Title Priority Date Filing Date
SG329/93A SG32993G (en) 1985-03-21 1993-03-23 Therapeutic particles

Country Status (10)

Country Link
US (1) US4755387A (xx)
EP (1) EP0195476B1 (xx)
JP (1) JPS61275211A (xx)
AU (1) AU599020B2 (xx)
CA (1) CA1264035A (xx)
DE (1) DE3674440D1 (xx)
DK (1) DK133286A (xx)
HK (1) HK54293A (xx)
IE (1) IE58439B1 (xx)
SG (1) SG32993G (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
JP2936574B2 (ja) * 1989-03-07 1999-08-23 大正製薬株式会社 鎮痛剤
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
ES2202302T3 (es) * 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. Composicion masticable que libera un farmaco.
DE69328545T2 (de) * 1993-03-24 2001-07-05 Collaborative Laboratories Inc., East Setauket Kosmetisches Verabreichungssystem für Salizylsäure und Verfahren zur Herstellung desselben
US5447354A (en) * 1993-11-10 1995-09-05 Delp; Melvin D. Children's wagon top conversion assembly
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
DE69924735T2 (de) 1998-07-28 2006-01-19 Tanabe Seiyaku Co., Ltd. Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
WO2000013523A1 (en) * 1998-09-08 2000-03-16 Biovail International Ltd. Encapsulation of caffeine
WO2003097013A1 (en) * 2002-05-16 2003-11-27 Tecnofarma Corp. Mono-coating for powdered pharmaceuticals
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US20060204613A1 (en) * 2005-02-18 2006-09-14 Castro Armando J Chewing gum containing flavor delivery systems
US20060286200A1 (en) * 2005-04-18 2006-12-21 Castro Armando J Confections containing flavor delivery systems
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
JP7376582B2 (ja) * 2018-10-22 2023-11-08 イーオーイー オレオ ゲーエムベーハー 成形体への圧縮を目的とした粉末材料用添加剤
EP3870229A1 (de) * 2018-10-22 2021-09-01 IOI Oleo GmbH Additiv für ein zur verpressung zu formkörpern vorgesehenes pulver

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
DE1080265B (de) * 1958-09-30 1960-04-21 Bayer Ag Verfahren zur Herstellung von oral anzuwendenden Arzneimittel-zubereitungen mit protrahierter Wirkung aus Wirkstoffen und Schutzstoffen
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
BE640616A (xx) * 1962-12-19
GB1443923A (en) * 1972-05-02 1976-07-28 Shepard M Sustained release compositions
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
FR2287216A1 (fr) * 1974-10-09 1976-05-07 Narcisse Guy Nouvelle forme galenique d'administration de medicaments et medicaments prepares sous cette nouvelle forme
DE2451488B2 (de) * 1974-10-30 1978-11-23 Milkivit-Werke A. Trouw Gmbh, 4054 Nettetal Wiederkäuer-Beifutter
US4182778A (en) * 1978-05-17 1980-01-08 General Foods Corporation Encapsulation of vitamin and mineral nutrients
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier

Also Published As

Publication number Publication date
IE860725L (en) 1986-09-21
EP0195476A3 (en) 1987-05-27
HK54293A (en) 1993-06-11
EP0195476A2 (en) 1986-09-24
DK133286A (da) 1986-09-22
AU599020B2 (en) 1990-07-12
DK133286D0 (da) 1986-03-21
AU5564386A (en) 1987-10-08
IE58439B1 (en) 1993-09-22
JPS61275211A (ja) 1986-12-05
EP0195476B1 (en) 1990-09-26
DE3674440D1 (de) 1990-10-31
CA1264035A (en) 1989-12-27
US4755387A (en) 1988-07-05

Similar Documents

Publication Publication Date Title
GB8619566D0 (en) Drug particles
EP0222718A3 (en) Macroporous particles
GB8629406D0 (en) Therapeutic device
GB8608149D0 (en) Furazolidine dosage form
EP0195476A3 (en) Therapeutic particles
GB8619565D0 (en) Drug particles
GB8515207D0 (en) Therapeutic agents
GB8521275D0 (en) Therapeutic composition
GB8619564D0 (en) Drug particles
ZA864288B (en) Therapeutic agents
GB8630251D0 (en) Therapeutic composition
ZA869373B (en) Therapeutic system
GB8629568D0 (en) Therapeutic agent
GB8529533D0 (en) Treatment of particles
GR861115B (en) New medicine
GB8523878D0 (en) Therapeutic compounds
ZA862464B (en) Therapeutic particles
GR861428B (en) Therapeutic compounds
GB8529885D0 (en) Therapeutic agent
PH23677A (en) Therapeutic particles
GB8521342D0 (en) Medicament
GB8500394D0 (en) Spherodal particles
GB8501707D0 (en) Therapy
GB8500236D0 (en) Projecting particles
GB8503624D0 (en) Therapeutic agents